Eurofins Advinus Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 13-12-2024
- Paid Up Capital ₹ 9.20 M
as on 13-12-2024
- Company Age 11 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.57 M
as on 13-12-2024
- Revenue 36.36%
(FY 2023)
- Profit 63.59%
(FY 2023)
- Ebitda 75.11%
(FY 2023)
- Net Worth -9.06%
(FY 2023)
- Total Assets 12.07%
(FY 2023)
About Eurofins Advinus Lifesciences
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 9.20 M.
The company currently has active open charges totaling ₹3.57 M.
The Key Managerial Personnel (KMP) at Eurofins Advinus Lifesciences Private Limited India is Rajiv Malik as CEO. Neeraj Garg, Rajiv Malik, and Haladasappa Krishnappa serve as directors at the Company.
- CIN/LLPIN
U82990KA2013FTC071603
- Company No.
071603
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
28 Oct 2013
- Date of AGM
24 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Eurofins Advinus Lifesciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajiv Malik  | Managing Director | 31-Jul-2020 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Neeraj Garg | Director | 26-Jul-2024 | Current |
| Haladasappa Krishnappa | Additional Director | 22-Oct-2024 | Current |
Financial Performance and Corporate Structure Insights of Eurofins Advinus Lifesciences.
Eurofins Advinus Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 36.36% increase. The company also saw a substantial improvement in profitability, with a 63.59% increase in profit. The company's net worth dipped by a decrease of 9.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eurofins Advinus Lifesciences?
In 2023, Eurofins Advinus Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Eurofins Advinus Biopharma Services India Private LimitedActive 6 years 1 monthNeeraj Garg and Rajiv Malik are mutual person
- Eurofins Advinus Discovery Services Private LimitedActive 5 years 9 months
Neeraj Garg and Rajiv Malik are mutual person
- Eurofins Peenya Resources Private LimitedActive 19 years 7 months
Neeraj Garg and Rajiv Malik are mutual person
Eurofins Clinical Diagnostics Bangalore Private LimitedActive 9 years 9 daysNeeraj Garg is a mutual person
Adgyl Lifesciences Private LimitedActive 6 years 23 daysNeeraj Garg, Rajiv Malik and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 14 May 2024 | ₹2.42 M | Open |
Axis Bank Limited Creation Date: 09 May 2024 | ₹1.15 M | Open |
How Many Employees Work at Eurofins Advinus Lifesciences?
Unlock and access historical data on people associated with Eurofins Advinus Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eurofins Advinus Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eurofins Advinus Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
